Skip to main content

Nonprofit · EIN 27-3232063

CANCER GENOMICS CONSORTIUM

Tax-exempt · FLETCHER, NC 28732

Financials

$441K$447K2023$437K$469K2024$512K$498K2025
Revenue Expenses · by fiscal year end
Financials of CANCER GENOMICS CONSORTIUM by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2025990$511,818$498,411$13,407$571,996$84,722$487,274
December 31, 2024990$436,621$469,290-$32,669$555,502$81,635$473,867
December 31, 2023990$441,040$446,547-$5,507$580,120$73,584$506,536
Financial details: 990 for the year ended December 31, 2025

Revenue

Contributions, gifts and grants
$15,098
Program service revenue
$477,467
Investment income
$19,253
Other revenue
$0

Expenses

Grants and similar amounts paid
$0
Salaries, compensation and benefits (total)
$0
Professional fundraising fees
$0
Legal fees
$17,039
Accounting fees
$4,800
Travel
$21,636
Program services (functional)
$433,276
Management and general (functional)
$53,262
Fundraising (functional)
$11,873

Balance sheet and other

Total assets, start of year
$555,502
Total assets, end of year
$571,996
Total liabilities, end of year
$84,722
Net assets, end of year
$487,274
Net assets without donor restrictions
$487,274
Gross receipts
$511,818
Employees
0
Volunteers
127
Year formed
2010
State of legal domicile
LA

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2025, highest compensation first.

NameTitleHours / weekCompensation
ADAM SMITH PHD FACMG CANCER CYTOGENETICS LABORATORYBOARD MEMBER
Trustee or director
0.5$0
ALEX H WAGNER PHD THE OHIO STATE UNIVERSITYBOARD MEMBER
Trustee or director
0.5$0
CATE RANDALL PASCHAL PHD FACMG SEATTLE CHILDREN'S HOSPITALPRESIDENT -
Trustee or director, Officer
1$0
CELESTE ENO PHD FACMG CEDARS-SINAI MEDICAL CENTERTREASURER
Trustee or director, Officer
1$0
ANGELA LAGER PHD FACMGSECRETARY
Trustee or director, Officer
1$0
FADY MIKHAIL MD PHD FACMG UNIVERSITY OF ALABAMA AT BIRMINGHAMPRESIDENT
Trustee or director, Officer
1$0
JANE HOULDSWORTH EL NAGGAR PHD MOUNT SINAI HEALTH SYSTEMPAST - PRESI
Trustee or director, Officer
1$0
KILANNIN KRYSIAK PHD FACMG WASHINGTON UNIVERSITY SCHOOL OF MEDBOARD MEMBER
Trustee or director
0.5$0
MEGAN FORREST PHDJUNIOR BOARD
Trustee or director
0.5$0
WESLEY GOAR PHDJUNIOR BOARD
Trustee or director
0.5$0
RASHMI KANAGAL-SHAMANNA MDBOARD MEMBER
Trustee or director
0.5$0
T NIROSHI SENARATNE PHD FACMG UNIVERSITY OF CALIFORNIA LOS ANGELESBOARD MEMBER
Trustee or director
0.5$0
TREVOR PUGH PHD FACMG PRINCESS MARGARET CANCER CENTERBOARD MEMBER
Trustee or director
0.5$0
990 for the year ended December 31, 2024: 13 people
NameTitleHours / weekCompensation
ADAM SMITH PHD FACMG CANCER CYTOGENETICS LABORATORYBOARD MEMBER
Trustee or director
0.5$0
CASEY BREWER PHD FACMG CINCINNATI CHILDREN'S HOSPITALJUNIOR BOARD
Trustee or director
0.5$0
CATE RANDALL PASCHAL PHD FACMG SEATTLE CHILDREN'S HOSPITALSECRETARY
Trustee or director, Officer
1$0
CELESTE ENO PHD FACMG CEDARS-SINAI MEDICAL CENTERTREASURER
Trustee or director, Officer
1$0
ANGELA LAGER PHD FACMGBOARD MEMBER
Trustee or director
0.5$0
FADY MIKHAIL MD PHD FACMG UNIVERSITY OF ALABAMA AT BIRMINGHAMPRESIDENT -
Trustee or director, Officer
1$0
JANE HOULDSWORTH EL NAGGAR PHD MOUNT SINAI HEALTH SYSTEMPRESIDENT
Trustee or director, Officer
1$0
KILANNIN KRYSIAK PHD FACMG WASHINGTON UNIVERSITY SCHOOL OF MEDBOARD MEMBER
Trustee or director
0.5$0
WESLEY GOAR PHDJUNIOR BOARD
Trustee or director
0.5$0
RASHMI KANAGAL-SHAMANNA MDPAST - PRESI
Trustee or director, Officer
0.5$0
T NIROSHI SENARATNE PHD FACMG UNIVERSITY OF CALIFORNIA LOS ANGELESBOARD MEMBER
Trustee or director
0.5$0
TERESA SMOLAREK PHD FACMG CINCINNATI CHILDREN'S HOSPITALBOARD MEMBER
Trustee or director
0.5$0
TREVOR PUGH PHD FACMG PRINCESS MARGARET CANCER CENTERBOARD MEMBER
Trustee or director
0.5$0
990 for the year ended December 31, 2023: 13 people
NameTitleHours / weekCompensation
ADAM SMITH PHD FACMG CANCER CYTOGENETICS LABORATORYBOARD MEMBER
Trustee or director
0.5$0
ALAA KOLEILAT PHD MAYO CLINICJUNIOR BOARD
Trustee or director
0.5$0
CASEY BREWER PHD CINCINNATI CHILDREN'S HOSPITALJUNIOR BOARD
Trustee or director
0.5$0
CATE RANDALL PASCHAL PHD FACMG SEATTLE CHILDREN'S HOSPITALBOARD MEMBER
Trustee or director
0.5$0
CELESTE ENO PHD FACMG CEDARS-SINAI MEDICAL CENTERBOARD MEMBER
Trustee or director
0.5$0
FADY MIKHAIL MD PHD FACMG UNIVERSITY OF ALABAMA AT BIRMINGHAMSECRETARY
Trustee or director, Officer
1$0
JANE HOULDSWORTH PHD MOUNT SINAI HEALTH SYSTEMPRESIDENT -
Trustee or director, Officer
1$0
KILANNIN KRYSIAK PHD FACMG WASHINGTON UNIVERSITY SCHOOL OF MEDBOARD MEMBER
Trustee or director
0.5$0
NIROSHI SENARATNE PHD FACMG UNIVERSITY OF CALIFORNIA LOS ANGELESBOARD MEMBER
Trustee or director
0.5$0
OBI L GRIFFITH PHDPAST - PRESI
Trustee or director, Officer
0.5$0
RASHMI KANAGAL-SHAMANNA MDPRESIDENT
Trustee or director, Officer
1$0
TERESA SMOLAREK PHD CINCINNATI CHILDREN'S HOSPITALBOARD MEMBER
Trustee or director
0.5$0
TREVOR PUGH PHD FACMG PRINCESS MARGARET CANCER CENTERBOARD MEMBER
Trustee or director
0.5$0

Address and contacts

Address (IRS master file)
32 WHITE PINE CIR, FLETCHER, NC 28732-9462
Mailing address (990-N for 2011)
1430 Tulane Avenue, New Orleans LA 70112
Principal officer (990 for 2025)
FADY MIKHAIL MD PHD FACMG UNIVERSITY OF ALABAMA AT BIRMINGHAM, 32 WHITE PINE CIRCLE, FLETCHER, NC 28732
Principal officer (990-N for 2011)
Mariilyn Li MD, One Baylor Plaza, Houston TX 77030
Signed the 990
FADY MIKHAIL MD PHD FACMG, PRESIDENT
Phone
(608) 772-2963
Return prepared by
GOULD KILLIAN CPA GROUP PA

Mission

THE CANCER GENOMICS CONSORTIUM (CGC) IS COMMITTED TO PROVIDING HIGH QUALITY EDUCATION AND PROMOTING BEST LABORATORY PRACTICES IN CLINICAL CANCER GENOMICS.

990 for the year ended December 31, 2025

Program accomplishments

  • ANNUAL MEETING - A UNIQUE GATHERING AIMED AT BRINGING THE GLOBAL CLINICAL GENOMIC COMMUNITY TOGETHER TO CREATE AN INCLUSIVE ENVIRONMENT OF COLLABORATION, EDUCATION, NETWORKING AND MENTORSHIP. WITH THE CONTINUING INTER-DISPLINARY PARTNERSHIPS BETWEEN CLINICAL GENOMICISTS (CYTOGENETIC & MOLECULAR), BIOINFORMATICIANS, GENOMIC VARIANT SCIENTISTS, LABORATORY DIRECTORS, RESEARCH SCIENTISTS, PATHOLOGISTS AND ONCOLOGISTS. CGC IS COMMITTED TO PLAYING AN ESSENTIAL ROLE IN TRANSLATING SCIENTIFIC DISCOVERIES INTO THE CLINICAL DIAGONOSTICS SETTING FOR PATIENT CARE AND GUIDING THE BEST PRACTICE TO ENABLE PRECISION MEDICINE AT THE HIGHEST LEVEL. THE MEETING WILL INCLUDE INVITED SCIENTIFIC PRESENTATIONS FROM LEADING SCIENTISTS AND PROFESSIONALS, SELECTED PLATFORM AND POSTER PRESENTATIONS, ROUND TABLE DISCUSSIONS ON TOPICS, EDUCATIONAL WORKSHOPS AS WELL AS AMPLE OPPORTUNITIES TO NETWORK WITH THE INDUSTRY PARTNERS.
    Expenses $347,048
  • OTHER PROGRAMS - THE CGC EARLY CAREER INITIATIVE COMMITTEE ORGANIZES AND PROMOTES INITIATIVES WITHIN CGC TO DEVELOP A COMMUNITY, FACILITATE NETWORKING, AND PROMOTE THE ENGAGEMENT OF EARLY CAREER MEMBERS. THE GOALS OF THE CGC EARLY CAREER COMMITTEE IS TO DEVELOP A COMMUNITY AMONG EARLY CAREER MEMBERS OF THE CGC AND PROVIDE RESOURCES INCLUDING NETWORKING OPPORTUNITIES, MENTORSHIP, BOARD EXAM PREPARATION, JOB SEARCH ADVICE, AND SOCIAL EVENTS. THE EARLY CAREER INITIATIVE COMMITTEE LIAISES WITH OTHER CGC COMMITTEES, INCLUDING THE EDUCATION, MEMBERSHIP, PROGRAM, AND COMMUNICATIONS, IN ORDER TO FURTHER THE INTERESTS OF EARLY CAREER MEMBERS. IN ADDITION, CGC HAS WEBINARS SERIES THAT FOCUSES ON TOPICS OF HIGH INTEREST FOR CGC MEMBERS AND ATTENDEES OF THE CGC ANNUAL MEETING, INCLUDING IMPLEMENTATION OF NEW TECHNOLOGIESIN CLINICAL GENOMIC TESTING, STANDARDS AND RESOURCES FOR INTERPRETATION OF SEQUENCE AND COPY NUMBER VARIANTS, GREMLINE PREDISPOSTIONS TO CANCER, AND NOVEL APPROACHES FOR DETECTION OF STRUCTURAL VARIANTS IN CONSTITUTIONAL AND CANCER SAMPLES.
    Expenses $77,054
  • COMPENDIUM OF CANCER GENOME ABERRATIONS - CCGA IS A COLLABORATIVE PROJECT TO DOCUMENT GENOMIC ABERRATIONS IN CANCER BASED ON THE WHO CLASSIFICATION STRUCTURE AS AN EDUCATIONAL RESOURCE FOR DAY-TO-DAY USE IN CLINICAL CASE INTERPRETATION. HOSTED ON A WIKI PLATFORM, THE CCGA IS DESIGNED TO PROVIDE UP-TO-DATE AND INTEGRATIVE CONTENT, HIGHLIGHTING ACTIONABLE AND DIAGNOSTICALLY-IMPORTANT FEATURES.
    Expenses $9,174

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026990 on file
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990 on file

IRS record

EIN
27-3232063
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (509(a)(2))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
2014
Accounting year ends
December
Files
Form 990 or 990-EZ
Category (NTEE)
Medical research (H12)
Assets (IRS master file)
$571,996
Income (IRS master file)
$511,818

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2025$511,818$498,411$571,996XML
990December 2024$436,621$469,290$555,502IRS
990December 2023$441,040$446,547$580,120XML
990December 2022$471,897$380,318$534,562IRS
990December 2021–––IRS
990December 2020–––IRS
990December 2019–––IRS
990December 2018–––IRS
990-N for 2011
Officer: Mariilyn Li MD
December 31, 2011≤ $50,000 receipts––e-Postcard

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 27-3232063).

Questions about CANCER GENOMICS CONSORTIUM

What is the EIN of CANCER GENOMICS CONSORTIUM?
The employer identification number (EIN) of CANCER GENOMICS CONSORTIUM is 27-3232063.
Is CANCER GENOMICS CONSORTIUM tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2014.
Are donations to CANCER GENOMICS CONSORTIUM tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does CANCER GENOMICS CONSORTIUM file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of CANCER GENOMICS CONSORTIUM due?
The return for tax year 2026 (the year ending December 31, 2026) is due May 17, 2027. Form 8868 extends it by six months; the 990-N cannot be extended.
When did CANCER GENOMICS CONSORTIUM last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2025.
Who is the principal officer of CANCER GENOMICS CONSORTIUM?
The 990 for the year ended December 31, 2025 names FADY MIKHAIL MD PHD FACMG UNIVERSITY OF ALABAMA AT BIRMINGHAM.
Who are the officers and directors of CANCER GENOMICS CONSORTIUM?
The 990 for the year ended December 31, 2025 lists 13 people; 0 received compensation from the organization.
How much revenue does CANCER GENOMICS CONSORTIUM have?
On its 990 for the year ended December 31, 2025 it reported revenue of $511,818, expenses of $498,411 and total assets of $571,996 at year end.

Other nonprofits in FLETCHER

All nonprofits in FLETCHER · North Carolina · Medical research